Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entry encompasses three major members of the human selenoproteome: Glutathione peroxidase (GPx), Thioredoxin reductase (TrxR), and Selenoprotein P (SELENOP). These proteins are characterized by the presence of selenocysteine in their active sites, which confers high catalytic efficiency in redox reactions (UniProt P07203). Glutathione peroxidases function primarily to reduce hydrogen peroxide and organic hydroperoxides, protecting cells from oxidative stress-induced damage (PubMed: 29129946). Thioredoxin reductases maintain the pool of reduced thioredoxin, which is essential for DNA synthesis via ribonucleotide reductase and for regulating various redox-sensitive transcription factors (UniProt Q16881). Selenoprotein P acts as the primary vehicle for selenium transport from the liver to peripheral tissues and provides extracellular antioxidant defense (UniProt P49908). In oncology, TrxR is often upregulated to support rapid proliferation, making it a target for inhibitors like auranofin (PubMed: 30114478). Conversely, GPx mimics like ebselen are investigated for their ability to mitigate oxidative damage in inflammatory and neurodegenerative conditions (PubChem CID 3194). The collective activity of these proteins is a critical determinant of a cell's ability to survive under conditions of high reactive oxygen species (ROS) production.
Inhibition of thioredoxin reductase to induce oxidative stress and apoptosis in cancer cells; mimicry of glutathione peroxidase activity to neutralize reactive oxygen species; and supplementation of selenium to facilitate the biosynthesis of functional selenoproteins.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glutathione peroxidase, Thioredoxin reductase, and Selenoprotein P (GPx, TrxR, SELENOP).